Rahul A Parikh (Rahul Parikh)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 13

Top Topics

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO oncology practice

International journal of molecular imaging

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Rohan Garje, Thomas A Hope, R Bryan Rumble, Rahul A Parikh, null null
Systemic Therapy Update on 177 Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A. JCO oncology practice 19 (3) (2023)
Rohan Garje, Thomas A Hope, R Bryan Rumble, Rahul A Parikh, null null
Systemic Therapy Update on 177 Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A. JCO oncology practice 19 (3) (2023)
Rohan Garje, Thomas A Hope, R Bryan Rumble, Rahul A Parikh, null null
Systemic Therapy Update on 177 Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A. JCO oncology practice (2023)
Elizabeth Pan, Wanling Xie, Archana Ajmera, Arlene Araneta, Christina A M Jamieson, Edmund Folefac, Arif Hussain, Christos E Kyriakopoulos, Adam C Olson, Mamta Parikh, Rahul A Parikh, Biren Saraiya, Susan Percy Ivy, Eliezer Van Allen, Neal I Lindeman, Bose S Kochupurakkal, Geoffrey I Shapiro, Rana R McKay
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Molecular cancer therapeutics (2023)
Rohan Garje, Thomas A Hope, R Bryan Rumble, Rahul A Parikh, null null
Systemic Therapy Update on 177 Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A. JCO oncology practice 19 (3) (2023)
Rohan Garje, R Bryan Rumble, Rahul A Parikh, null null
Systemic Therapy Update on 177 Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rohan Garje, R Bryan Rumble, Rahul A Parikh
Systemic Therapy Update on 177 Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (31) (2022)
Sarmad Sadeghi, David I Quinn, Tanya Dorff, Sumanta Kumar Pal, Susan Groshen, Denice Tsao-Wei, Rahul A Parikh, Michael Devitt, Mamta Parikh, Alexandra Jackovich, Nora Ruel, Nicholas J Vogelzang, Earle Burgess, Imran Siddiqi, Inderbir S Gill, Primo N Lara, Robert Dreicer, Parkash S Gill
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Nghi C Nguyen, Muhammad Shah, Leonard J Appleman, Rahul A Parikh, James M Mountz
Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case Presentation. International journal of molecular imaging 2016 (2016)